Tax included


Security policy


Delivery policy


Return policy

The combination of lincomycin and spectinomycin has an additive mode of action, and in many cases acts synergistic. Lincomycin has a bacteriostatical mode of action against mainly Gram-positive bacteria (like Staphylococcus aureus, Streptococcus pyogenes, Str. suis, Str. agalactia, Diplococcus pneumonia, Corynebacterium pyogenes, Clostridium perfringens, Cl. tetani and Pasteurella multocida). Enterococci and Gram-negative bacteria are hardly sensitive. Anaerobe micro-organisms are very sensitive, like Bacteroides spp. and Fusibacterium spp. (Doyle-dysentery) and Mycoplasmas (like M. galli septicum, M. hyosynovia, M. meleagridis, M. canis and M. hyorhinis; M. pneumonia is hardly sensitive).

Spectinomycin has a broad bacteriostatical spectrum. Sensitive for spectinomycin are especially the Gram-negative and some Gram-positive bacteria (like Aerobacter aerogenes, E. coli, Klebsiella pneumonia, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella spp., Vibrio coli and Diplococcus pneumonia). Furthermore spectinomycin is active against Mycoplasmas (like M. gallisepticum, M. meleagridis and M. synvia). Cross-resistance of lincomycin with erythromycin and other macrolides is rule.


Specific References

For intramuscular or subcutaneous injection.

Calves, pigs, sheep, goats : 1 ml per 10 kg bodyweight daily, during 3 – 7 days.

Dogs, cats : 1 ml per 5 kg bodyweight daily, during a maximum of 3 days.

Poultry, turkeys : 0.2 ml per kg bodyweight daily, during a maximum of 3 days.

Contains per ml:

Lincomycin (as HCl H2O) 50 mg

Spectinomycin (as 2HCl 5H2O) 100 mg